highly significantp < 0.001
However, a highly significant effect for symptom reduction over time was found in both groups ( p < 0.001 for the main effect time ).
However, a highly significant effect for symptom reduction over time was found in both groups ( p < 0.001 for the main effect time ).
On the other hand, we found a positive trend towards superiority of add-on active iTBS also in clinician-rated general functioning (GAF; Cohen’s d for group difference after 4 weeks, 0.32), whereas self-assessed self-compassion (SCS) was similar in both groups (d = 0.03).